Effect of home-based cardiac rehabilitation on 30-day readmission among patients after cardiac surgery
Published
April 29, 2026
Paper ID
PAP-000122
Status
Published
DOI
10.65712/tmj.test000380
Advance Services
Abstract
Background: 30-day readmission remains a leading cause of avoidable harm among patients after cardiac surgery. Methods: We conducted a prospective cohort study across 6 centres between 2020 and 2022. Results: The adjusted odds ratio was 0.81 (95% CI 0.37 to 0.72). 453 participants were included (median age 70 years). Conclusion: These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery.
Introduction
Earlier studies of home-based cardiac rehabilitation were small or single-centre. Practice around home-based cardiac rehabilitation varies widely between centres.
Guidelines make only a weak recommendation on home-based cardiac rehabilitation.
Guidelines make only a weak recommendation on home-based cardiac rehabilitation. The cost of 30-day readmission to health systems is substantial.
The cost of 30-day readmission to health systems is substantial. Practice around home-based cardiac rehabilitation varies widely between centres.
Materials and Methods
Eligible participants were patients after cardiac surgery. Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 6 centres between 2017 and 2022. We conducted a prospective cohort study across 11 centres between 2020 and 2022.
We conducted a prospective cohort study across 8 centres between 2014 and 2025. Missing data were handled with multiple imputation.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 4 centres between 2017 and 2025.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. 30-day readmission occurred in 16% of the intervention group versus 34% of controls. 30-day readmission occurred in 5% of the intervention group versus 37% of controls. 4762 participants were included (median age 81 years).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Intervention | 602 | 111 | 32.8 | 0.91 | 0.49–1.0 |
| Age ≥ 65 | 878 | 111 | 2.0 | 0.66 | 0.39–1.38 |
| Centre B | 491 | 21 | 37.4 | 0.65 | 0.46–1.16 |
| Centre A | 462 | 50 | 34.7 | 0.45 | 0.41–1.39 |
| Intervention | 401 | 24 | 23.1 | 0.88 | 0.56–1.13 |
| Control | 186 | 26 | 25.4 | 0.43 | 0.23–1.26 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
30-day readmission occurred in 18% of the intervention group versus 28% of controls. 2878 participants were included (median age 58 years).
Discussion
Residual confounding cannot be excluded. These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.
These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery. Strengths include the sample size and blinded outcome assessment.
Conclusions
Home-based cardiac rehabilitation merits wider use for patients after cardiac surgery to improve 30-day readmission.
References
1. Kowalski Z, Herrera Q, et al. High-flow nasal oxygen and medication adherence. Ann Intern Med. 2009;396(4):60-1654.
2. Farouk I, Ibrahim B, et al. Point-of-care ultrasound and 30-day readmission. N Engl J Med. 2016;268(4):407-1767.
3. Dubois G, Haddad E, et al. Tranexamic acid and 30-day readmission. BMJ. 2023;152(10):645-1291.
4. Ahmed G, Costa L, et al. Vitamin D supplementation and chronic pain scores. N Engl J Med. 2024;33(1):391-1254.
5. Yilmaz I, Rossi L, et al. A sepsis alert system and 30-day readmission. BMJ. 2014;211(3):590-1119.
6. Dubois C, Nasser O, et al. Tranexamic acid and length of stay. BMJ. 2023;232(11):504-1415.
7. Osei G, Moreau R, et al. Tranexamic acid and emergency department revisits. Lancet. 2010;29(11):453-1645.
8. Mensah C, Rossi O, et al. Vitamin D supplementation and surgical site infection. Eur Heart J. 2024;190(3):342-1558.
9. Rossi J, Kowalski I, et al. High-flow nasal oxygen and time to diagnosis. BMC Med. 2011;280(6):754-1721.
10. Lindqvist G, Yilmaz Q, et al. Machine-learning triage and ventilator-free days. BMC Med. 2010;12(10):473-1755.
Appendices
Ethics approval: IRB-8375.